The ZNF35 human zinc finger gene encodes a sequence-specific DNA-binding protein  by Pengue, Gina et al.
Volume 321, number 2,3, 233-236 FEBS 12357 
0 1993 Federation of European Biochemical Societies 00145793/93/$6.00 
April 1993 
The ZNF35 human zinc finger gene encodes a sequence-specific 
DNA-binding protein 
Gina Pengue, Paola Cannada-Bartoli and Luigi Lania 
Dipartimento di Genetica, Biologia Generale e Molecolare, University of Naples, Via Mezzocannone 8, 80134 Naples, Italy 
Received 28 January 1993 
We developed a rapid method to determine DNA-binding sites for putative DNA-binding proteins. This procedure has been successfully used to 
define a specific consensus ite for the human ZNF35 zinc finger gene. ZNF35 encodes a 58-kDA polypeptide containing 11 consecutive finger 
motifs located at the amino terminus, and an acidic domain located at the carboxy terminus. These features uggest hat ZNF35 is a site-specific 
DNA-binding protein involved in the regulation of gene expression. We have expressed the ZNF35 protein from E. coli and have employed a 
Southwestern-polymerase chain reaction method using random oligonucleotides to identify its high-affinity binding site. The core sequence for the 
ZNF35 protein-binding site is 5’-CYGClGAAGfTA-3’. 
DNA-binding protein; Zinc finger protein; DNA-binding site 
1. INTRODUCTION 
In recent years a large number of DNA-binding pro- 
teins have been cloned based on evolutionary conserved 
homologies in their DNA binding domain, e.g. homeo 
domains [l], pou-boxes [2], paired boxes [3,4] and zinc 
finger regions [5-91. However, the DNA sequences to 
which the various domains bind have been determined 
only for relatively few proteins [lO-141. Our group has 
cloned a number of human genes encoding zinc finger 
domains from both human placenta and T cell cDNA 
libraries [8,15]. Some of these genes have been shown to 
be involved in regulation of myeloid cell differentiation 
P,151. 
We designed the Random Oligonucleotide Blot 
(ROB) procedure in order to determine the DNA recog- 
nition sites for these zinc finger proteins. The method 
required the production of a bacterial synthesized 
human zinc finger protein and a pool of randomized 
oligonucleotides. Template oligonucleotides were chem- 
ically synthesized to contain random nucleotides sur- 
rounded by specific sequences with appropriate restric- 
tion sites on either end. The primers (5’, primer A and 
3’, primer B), complementary to the sequences at the 
ends of the template oligonucleotides, were used for 
PCR amplification. In this report we describe a simple 
method with which the double-stranded oligonucleo- 
tides containing random nucleotides can be used in a 
Southwestern experiment for determining high-affinity 
binding sites for the human ZNF35 zinc finger protein. 
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2. MATERIALS AND METHODS 
2.1. Plasmid construction and expression in E. coli 
To express a ZNF35 zinc finger containing fragment in E. coli under 
the control of the T7 RNA polymerase-dependent Q, promoter [16], an 
expression plasmid was constructed by inserting a 2230 bp NcoI frag- 
ment derived from the full-length ZNF35 cDNA into the SmaI site of 
the plasmid vector pT7-7, via blunt ligation. The expression vector was 
transformed into E. coli strain BL21 (LysS) [16]. Cells were grown in 
LB medium to an OD, of 0.5 and expression was induced by adding 
isopropyl-/I-o-thiogalactopyranoside (IPTG) to a final concentration 
of 0.5 mM. After 2 h at 37”C, the bacteria were harvested and extracts 
prepared according to the procedure described for Spl [17]. 
2.2. Random Oligonucleotide Blot (ROB) analysis 
The following oligonucleotides were used: random sequence ol- 
igonucleotide N; 5’-AGACGGATCCATTGCA-(N)&TGTAG- 
GAATTCGGA-3’; primer A; 5’-TCCGAATTCCTACAG-3’; primer 
B, 5’-AGACGGATCCATTGCA-3’. The oligonucleotide N was ren- 
dered double-stranded by primed synthesis using primer A and Kle- 
now fragment, in the presence of 32P-nucleotides. The labeled ol- 
igonucleotides were used in Southwestern blot hybridization as de- 
scribed [18]. Briefly, the bacterially produced proteins (15 pg) were 
electrophoresed on SDS polyacrylamide gels and electro-transfered to
nitrocellulose. The nitrocellulose filters were rinsed in 5% non-fat milk 
in buffer A (10 mM Tris-HCl pH 8,50 mM NaCl, 1 mM EDTA pH 
8) to denature the proteins. The nitrocellulose blot and the 32P random 
oligonucleotides were incubated overnight at 4°C in buffer A contain- 
ing 50 mM NaCl. The filters were washed twice at 4°C in buffer A 
containing 100 mM NaCl and exposed to film for 16 h. Identical 
results were observed when filters were washed with 100 mM and 300 
mM NaCl. The radiolabeled band was cut from the filter, the DNA 
was eluted, then was subjected to PCR using the A and B primers for 
20 cycles with 1 U Amplitaq polymerase (Cetus). Amplification was 
performed at 94°C for 1 min, 42°C for 1 min, and 72°C for 2 min. 
The probe was purified by gel electrophoresis and quantitated by 
Cerenkov counting. After four cycles the PCR products were cloned 
in pUC8 by taking advantage of the presence of the EcoRI and EamHI 
sites present in the PCR products. 26 independent plasmid inserts were 
sequenced. 
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2.3. Gel retardation experiments 
Gel retardation assays (EMSA) were essentially performed as de- 
scribed [19]. Bacterial extracts from induced cells were mixed with 
radiolabeled 45 bp EcoRI-BamHI fragments derived from the indi- 
cated ROB selected clones; competition experiments were performed 
using loo-fold molar excess of the same unlabeled fragments. Oligonu- 
cleotides for SPl and API binding sites were used as unspecific om- 
petitors. 
3. RESULTS 
The predicted amino acid sequence of ZNF35 con- 
tains an acidic region at the amino terminus and eleven 
contiguous zinc fingers of the Cys,-His, class at the 
carboxy terminus [9,20]. The presence of these two 
structural motifs implies that the ZNF35 protein is a 
sequence-specific nucleic acid-binding protein that may 
function as a transcriptional regulator. In this report we 
have initiated a biochemical characterization of the 
ZNF35 protein by identifying a DNA target sequence 
which it recognizes. Our strategy was to express the 
ZNF35 protein in E. coli and to use this protein in 
Southwestern blot experiments for the isolation of a 
DNA target sequence. The ZNF35 cDNA was cloned 
in the bacterial expression vector pT7-7 as described in 
section 2, and the bacterial protein (termed bZNF35) 
migrated with an apparent molecular size of 58,000 kDa 
on SDS-polyacrylamide gels (Fig. 1A). Southwestern 
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Fig. 1. SDS-PAGE and Southwestern analysis of bZNF35 protein. (A) 
Coomassie blue-stained SDS-PAGE; lane N, non-induced bacterial 
extract; lane I, extract from IPTG induced cells. (B) Southwestern of 
non-induced and induced E. coli cell extracts probed with ‘*P-labeled 
ds random oligonucleotides. The arrows indicate the position of the 
bZNF35 protein. 
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Fig. 2. Random oligonucleotide blot (ROB). The ROB assay requires 
a bacterial synthesized DNA-binding protein and a pool of random 
oligonucleotides. Selected oligonucleotides are subjected to further 
ROB cycles. Finally, the ROB-selected oligonucleotides are cloned, 
analyzed and sequenced. 
experiments of the bacterial proteins indicated that the 
bZNF35 is capable of binding to DNA (Fig. 1B). 
A modification of the method developed by Treaty 
et al. [18] was used to isolate DNA sequences that were 
recognized specifically by the bZNF35 (Fig. 2). A de- 
generate oligonucleotide that contained random nucleo- 
tides at 20 consecutive positions flanked by a defined 
sequence was chemically synthesized. The 50-base sin- 
gle-strand synthetic oligonucleotide (N) was used as a 
template for second-strand synthesis, which was per- 
formed with primer A and DNA polymerase in the 
presence of deoxynucleotide triophosphates, and a com- 
plementary degenerate library of double stranded ol- 
igonucleotides was obtained. To identify putative target 
sequences for ZNF35, we utilized a procedure that 
involved immobilizing bacterially produced ZNF35 
protein on nitrocellulose membrane, renaturation and 
incubation with the pool of 32P-labeled ouble-stranded 
oligonucleotides containing 20 consecutive random 
base pairs. The specific bound DNA was then eluted 
and amplified by using the defined flanks as primer sites 
in a PCR. The amplified DNA was then subjected to 
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-GAACCCCAAOACGTATCATG- 
- CCACCCAAOOCGCCCCCCTG- 
- GCGGOCAAOOCAGGTTCATA- 
GGCCAAOTCTCCCATTGTCG- 
- GGGGCCAAOAGATGTATC- 
- GGGGOCAACATATACCGGG- 
- CCCACCAAOAGCTCCACGTG- 
GCCCAAOAGTACGTATCCTG- 
- CCCAOCAAOATACACCTTCG- 
- GGGGAOAAOAGTAATCGGTG- 
-CACCGOOAATACTTACCATG- 
- CCCTOOAATACGCCGCCTT- 
- CACGTOAATAATGGACCGTG- 
- CATAOOAAOTGCGGCCCAAG- 
-CAGAGAOAATCCACTG- 
-CACGAOOAATAGCTG- 
- GCGGCQAATAAGGCTGTTCG- 
- GGCAOOAAOATATGGGATA- 
-GGCGGOOAATACCACTCGTG- 
-CACACCCAATACGTTCCCTA- 
COII..I)‘U. I’-C/O C/O A A O/T A-3’ 
Fig. 3. Selected binding sites for bZNF35 protein. The sequences of 
20 cloned ZNF35 binding sites derived from four rounds of ROB 
selection are shown and aligned. The limits of the central 6 bases are 
indicated by boldface letters. At the bottom is the consensus equence. 
three additional cycles of binding and amplification. 
The DNA recovered after four rounds of selection was 
analyzed following purification by molecular cloning 
and DNA sequencing, and results are shown in Fig. 3. 
Of 20 cloned oligonucleotides analyzed, a 6-bp long 
consensus sequence was identified in all of them. The 
consensus equence was S-C/GC/GAAG/TA-3’. 
To further show the binding specificity of bZNF35 to 
the 5’-C/GC/GAAGiTA-3’ sequence, we performed gel 
retardation assays (EMSA) in the presence of an unla- 
beled specific competitor (Fig. 4). As probes we used 
DNA fragments derived from the no. 36 and no. 18 
clones after digestion with EcoRI and BumHI, respec- 
tively. The presence of a loo-fold excess of the specific 
competitor inhibited the binding of the radiolabeled 
DNA fragment to the bacterial bZNF35. In addition, 
we found that the presence of non-specific competitors, 
such as the binding site for SPl and for APl proteins, 
did not have any effect on the binding (Fig. 4). 
4. DISCUSSION 
The identification of high-affinity binding sites in 
DNA for transcription factors is an important step in 
their characterization. In this paper, we present evi- 
dence that the human ZNF35 gene encodes a sequence- 
specific DNA-binding protein, and the core sequence of 
the binding site is 5’-C/GC/GAAG/TA-3’. This binding 
activity most likely resides in the carboxy terminus 
which contains 11 zinc fingers. To identify the ZNF35- 
binding site, we have used a modification of a technique 
described recently by Treaty et al. [18]. Definition of 
target sequences of various DNA proteins by random 
selection and PCR have been reported by several groups 
[18,21-241. We found that the major advantage of the 
technique is that the bacterially expressed protein re- 
quires no purification. In addition, it is possible to visu- 
alize directly the binding of the recombinant protein 
from the binding of the contaminant bacterial proteins 
(Fig. 1B). 
We noticed that the ZNF35 binding site is also pres- 
ent within the Evi-l-binding site. The Evi-1 is a finger 
gene originally identified as a common site of viral inte- 
gration in murine myeloid tumors [25]. The binding site 
for Evi-1, identified by the gel shift PCR method using 
random oligonucleotides, was found to be 
TGACAAGATAA, which contains the core sequence 
of the ZNF35-binding site (CAAGA). Therefore, it ap- 
pears that both ZNF35 and Evi-1 zinc-finger proteins 
might bind to a similar DNA sequence. It will be inter- 
esting to determine the transcription regulatory poten- 
tial of both ZNF35 and Evi-1 proteins on a reporter 
gene containing the ZNF35-binding site. It is pertinent 
to note that two human zinc finger genes, WT-1 and 
EGR-1, have been recently shown to bind to the same 
DNA sequences [26]. However, co-transfection experi- 
ments demonstrated that each protein has an opposite 
effect on transcription: the WT-1 acts a repressor, while 
the EGR-1 acts as an activator [27]. 
Several transcriptional activators contain acidic do- 
mains which most likely interact with other proteins in 
the transcriptional complex [28]. The presence of an 
acidic domain in the amino part of ZNF35 suggests that 
ZNF35 can function in vivo as a transcriptional activa- 
tor. We are currently investigating this possibility by 
constructing promoter sequences with the ZNF35-bind- 
ing site linked to reporter genes and assaying for ZNF35 
trans-activation by cotransfection. 
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Fig. 4. Characterization of ZNF35-binding sites. EMSA were per- 
formed using recombinant ZNF35 protein and the EcoRI-BarnHI 
inserts derived from clones no. 36 (left panel) and no. 18 (right panel) 
were used as probes. 100x molar excess of specific and non-specific 
unlabeled competitors (Spl and APl) were used as indicated. Lane 
(-), no competitor was added to the binding reactions. 
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